Scarica l'app Stockscreener
10.21
1.49%
0.15
Anika Therapeutics Inc Borsa (ANIK) Ultime notizie
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026 - GlobeNewswire
Published on: 2026-02-13 12:04:47 - baoquankhu1.vn
(ANIK) Volatility Zones as Tactical Triggers - Stock Traders Daily
Published on: 2026-02-11 15:28:04 - mfd.ru
Anika Therapeutics (NASDAQ:ANIK) Share Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
Positive week for Anika Therapeutics, Inc. (NASDAQ:ANIK) institutional investors who lost 41% over the past year - simplywall.st
Lumicell Appoints Cheryl R. Blanchard, Ph.D., To Board - citybiz
Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors - ChartMill
Cancer imaging firm Lumicell taps 30-year biotech veteran Cheryl Blanchard for board - Stock Titan
Anika Therapeutics Inc. (NASDAQ:ANIK) Short Interest Update - MarketBeat
Anika Therapeutics Inc. $ANIK Shares Acquired by Capital Management Corp VA - MarketBeat
Price-Driven Insight from (ANIK) for Rule-Based Strategy - Stock Traders Daily
ANIK INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Anika Therapeutics, Inc. - ACCESS Newswire
United States Joint Pain Injection Market to hit US$ 4.05 Billion - openPR.com
Anika Therapeutics Faces Investor Lawsuit Over Securities Violations - Intellectia AI
ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. - GlobeNewswire
ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders - GlobeNewswire Inc.
Anika Therapeutics Shares Plunge 27% After Clinical Trial Fails to Meet Primary Endpoints - Intellectia AI
ANIK Kirby McInerney LLP Investigates Potential Claims Involving Anika Therapeutics, Inc. - marketscreener.com
Aug Weekly: Is COFPRL being accumulated by smart moneyJuly 2025 Market Mood & Fast Gain Stock Tips - baoquankhu1.vn
(ANIK) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Can Anika Therapeutics Inc. stock withstand economic slowdownJuly 2025 Action & Growth Oriented Trade Recommendations - bollywoodhelpline.com
How Anika Therapeutics Inc. stock performs in rising dollar environmentFed Meeting & Smart Allocation Stock Tips - Bollywood Helpline
Anika Therapeutics Builds Focused Platform For Joint Health Care - Kalkine Media
Will Anika Therapeutics Inc. stock benefit from infrastructure spendingMarket Risk Report & Long Hold Capital Preservation Plans - ulpravda.ru
Anika Therapeutics (NASDAQ:ANIK) Given “Outperform” Rating at Barrington Research - Defense World
(ANIK) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Barrington Research Reiterates Outperform Rating for Anika Therapeutics (NASDAQ:ANIK) - MarketBeat
Anika Therapeutics (ANIK): Barrington Research Maintains Outperf - GuruFocus
Anika Therapeutics names Stephen Griffin as new CEO - Investing.com
Is Anika Therapeutics Inc. stock trading near support levels2025 Key Lessons & Risk Controlled Swing Alerts - Улправда
Anika Therapeutics Announces CEO Transition and Governance Changes - TipRanks
Will Anika Therapeutics Inc. (AKP) stock see insider accumulationMarket Sentiment Report & Growth Focused Stock Pick Reports - Улправда
Anika Therapeutics Announces Leadership Transition - Ortho Spine News
Is Anika Therapeutics Inc. (AKP) stock inflation resilientJuly 2025 PreEarnings & Growth Oriented Trade Recommendations - Улправда
How Anika Therapeutics Inc. stock reacts to inflationary pressuresJuly 2025 Review & Expert Verified Stock Movement Alerts - Улправда
Anika Therapeutics, Inc. Announces Chief Executive Officer Changes - MarketScreener
Anika Therapeutics names Stephen Griffin as new CEO By Investing.com - Investing.com Australia
Cosmetic Surgery Market Is Booming Worldwide 2025-2032 | - openPR.com
Anika Therapeutics Shares Plunge 27.42% After Clinical Trial Results Fail to Meet Primary Endpoints - Intellectia AI
How Low Can Anika Therapeutics Stock Really Go? - Trefis
Why Anika Therapeutics Inc. stock remains on watchlistsMarket Activity Report & Community Trade Idea Sharing - Улправда
Market Pulse: Why Anika Therapeutics Inc. stock is trending among retail tradersDip Buying & Daily Technical Forecast Reports - Улправда
Is Anika Therapeutics Inc. stock attractive for retirement portfolios2025 AllTime Highs & Low Risk Entry Point Guides - DonanımHaber
Why Anika Therapeutics Inc. stock could see breakout soonWeekly Investment Recap & Capital Protection Trading Alerts - DonanımHaber
Regenerative Medicine (Bone and Joint) Market Is Going to Boom | Anika Therapeutics, Inc, Arthrex, Inc. - openPR.com
Why Anika Therapeutics Inc. stock is trending among retail tradersQuarterly Profit Review & Expert Curated Trade Setup Alerts - Улправда
(ANIK) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Income Plays: Why Anika Therapeutics Inc. stock is trending among retail tradersJuly 2025 Macro Moves & Fast Gaining Stock Strategy Reports - Улправда
Anika Therapeutics’ Earnings Call: Growth Amid Challenges - MSN
Is the Options Market Predicting a Spike in Anika Therapeutics Stock? - sharewise.com
Is Anika Therapeutics Inc a good long term investmentTechnical Analysis Insights & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Europe Viscosupplementation Market Detailed In New Research - openPR.com
Responsive Playbooks and the ANIK Inflection - Stock Traders Daily
Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP - GlobeNewswire
What is the fair value estimate for Anika Therapeutics Inc. (AKP) stock in 2025CEO Change & Weekly Return Optimization Alerts - Newser
Can Anika Therapeutics Inc. (AKP) stock ride next bull market cycleIPO Watch & Short-Term Swing Trade Alerts - Newser
1.19%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):